#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines


The recent 2009 pandemic H1N1 virus infection in humans has resulted in nearly 5,000 deaths worldwide. Early epidemiological findings indicated a low level of infection in the older population (>65 years) with the pandemic virus, and a greater susceptibility in people younger than 35 years of age, a phenomenon correlated with the presence of cross-reactive immunity in the older population. It is unclear what virus(es) might be responsible for this apparent cross-protection against the 2009 pandemic H1N1 virus. We describe a mouse lethal challenge model for the 2009 pandemic H1N1 strain, used together with a panel of inactivated H1N1 virus vaccines and hemagglutinin (HA) monoclonal antibodies to dissect the possible humoral antigenic determinants of pre-existing immunity against this virus in the human population. By hemagglutinination inhibition (HI) assays and vaccination/challenge studies, we demonstrate that the 2009 pandemic H1N1 virus is antigenically similar to human H1N1 viruses that circulated from 1918–1943 and to classical swine H1N1 viruses. Antibodies elicited against 1918-like or classical swine H1N1 vaccines completely protect C57B/6 mice from lethal challenge with the influenza A/Netherlands/602/2009 virus isolate. In contrast, contemporary H1N1 vaccines afforded only partial protection. Passive immunization with cross-reactive monoclonal antibodies (mAbs) raised against either 1918 or A/California/04/2009 HA proteins offered full protection from death. Analysis of mAb antibody escape mutants, generated by selection of 2009 H1N1 virus with these mAbs, indicate that antigenic site Sa is one of the conserved cross-protective epitopes. Our findings in mice agree with serological data showing high prevalence of 2009 H1N1 cross-reactive antibodies only in the older population, indicating that prior infection with 1918-like viruses or vaccination against the 1976 swine H1N1 virus in the USA are likely to provide protection against the 2009 pandemic H1N1 virus. This data provides a mechanistic basis for the protection seen in the older population, and emphasizes a rationale for including vaccination of the younger, naïve population. Our results also support the notion that pigs can act as an animal reservoir where influenza virus HAs become antigenically frozen for long periods of time, facilitating the generation of human pandemic viruses.


Vyšlo v časopise: Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines. PLoS Pathog 6(1): e32767. doi:10.1371/journal.ppat.1000745
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000745

Souhrn

The recent 2009 pandemic H1N1 virus infection in humans has resulted in nearly 5,000 deaths worldwide. Early epidemiological findings indicated a low level of infection in the older population (>65 years) with the pandemic virus, and a greater susceptibility in people younger than 35 years of age, a phenomenon correlated with the presence of cross-reactive immunity in the older population. It is unclear what virus(es) might be responsible for this apparent cross-protection against the 2009 pandemic H1N1 virus. We describe a mouse lethal challenge model for the 2009 pandemic H1N1 strain, used together with a panel of inactivated H1N1 virus vaccines and hemagglutinin (HA) monoclonal antibodies to dissect the possible humoral antigenic determinants of pre-existing immunity against this virus in the human population. By hemagglutinination inhibition (HI) assays and vaccination/challenge studies, we demonstrate that the 2009 pandemic H1N1 virus is antigenically similar to human H1N1 viruses that circulated from 1918–1943 and to classical swine H1N1 viruses. Antibodies elicited against 1918-like or classical swine H1N1 vaccines completely protect C57B/6 mice from lethal challenge with the influenza A/Netherlands/602/2009 virus isolate. In contrast, contemporary H1N1 vaccines afforded only partial protection. Passive immunization with cross-reactive monoclonal antibodies (mAbs) raised against either 1918 or A/California/04/2009 HA proteins offered full protection from death. Analysis of mAb antibody escape mutants, generated by selection of 2009 H1N1 virus with these mAbs, indicate that antigenic site Sa is one of the conserved cross-protective epitopes. Our findings in mice agree with serological data showing high prevalence of 2009 H1N1 cross-reactive antibodies only in the older population, indicating that prior infection with 1918-like viruses or vaccination against the 1976 swine H1N1 virus in the USA are likely to provide protection against the 2009 pandemic H1N1 virus. This data provides a mechanistic basis for the protection seen in the older population, and emphasizes a rationale for including vaccination of the younger, naïve population. Our results also support the notion that pigs can act as an animal reservoir where influenza virus HAs become antigenically frozen for long periods of time, facilitating the generation of human pandemic viruses.


Zdroje

1. FioreAE

ShayDK

BroderK

IskanderJK

UyekiTM

2008 Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 57 1 60

2. PaleseP

ShawML

2007 Orthomyxoviridae: the viruses and their replication.

HowleyDMKPM

Fields virology. 5th edition Philadelphia, PA Lippincott Williams & Wilkins 1647 1689

3. CoxNJ

NeumannG

DonisRO

KawaokaY

2005 Orthomyxoviruses: influenza.

MahyBWJ

ter MeulenV

Topley and Wilson's microbiology and microbial infections London Hodder Arnold Press 634 698

4. Gillim-RossL

SubbaraoK

2006 Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev 19 614 636

5. SkehelJJ

WileyDC

2000 Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69 531 569

6. HorimotoT

KawaokaY

2005 Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3 591 600

7. MathewsJD

ChessonJM

McCawJM

McVernonJ

2009 Understanding influenza transmission, immunity and pandemic threats. Influenza Other Respi Viruses 3 143 149

8. NeumannG

KawaokaY

2006 Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis 12 881 886

9. WebsterRG

BeanWJ

GormanOT

ChambersTM

KawaokaY

1992 Evolution and ecology of influenza A viruses. Microbiol Rev 56 152 179

10. ScholtissekC

1994 Source for influenza pandemics. Eur J Epidemiol 10 455 458

11. TaubenbergerJK

MorensDM

2006 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 12 15 22

12. NelsonMI

ViboudC

SimonsenL

BennettRT

GriesemerSB

2008 Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog 4 e1000012 doi:10.1371/journal.ppat.1000012

13. VincentAL

MaW

LagerKM

JankeBH

RichtJA

2008 Swine influenza viruses a North American perspective. Adv Virus Res 72 127 154

14. NakajimaK

DesselbergerU

PaleseP

1978 Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature 274 334 339

15. ScholtissekC

von HoyningenV

RottR

1978 Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology 89 613 617

16. SencerDJ

MillarJD

2006 Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis 12 29 33

17. GaydosJC

TopFHJr

HodderRA

RussellPK

2006 Swine influenza a outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis 12 23 28

18. ShindeV

BridgesCB

UyekiTM

ShuB

BalishA

2009 Triple-reassortant swine influenza A (H1) in humans in the United States, 2005–2009. N Engl J Med 360 2616 2625

19. MyersKP

OlsenCW

GrayGC

2007 Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 44 1084 1088

20. DacsoCC

CouchRB

SixHR

YoungJF

QuarlesJM

1984 Sporadic occurrence of zoonotic swine influenza virus infections. J Clin Microbiol 20 833 835

21. WentworthDE

ThompsonBL

XuX

RegneryHL

CooleyAJ

1994 An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza. J Virol 68 2051 2058

22. DawoodFS

JainS

FinelliL

ShawMW

LindstromS

2009 Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360 2605 2615

23. ChowellG

BertozziSM

ColcheroMA

Lopez-GatellH

Alpuche-ArandaC

2009 Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361 674 679

24. 2009 Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009. MMWR Morb Mortal Wkly Rep 58 585 589

25. 2009 Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 84 185 189

26. PeirisJS

PoonLL

GuanY

2009 Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 45 169 173

27. HancockK

VeguillaV

LuX

ZhongW

ButlerEN

2009 Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361 1945 1952

28. ItohY

ShinyaK

KisoM

WatanabeT

SakodaY

2009 In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460 1021 1025

29. FodorE

DevenishL

EngelhardtOG

PaleseP

BrownleeGG

1999 Rescue of influenza A virus from recombinant DNA. J Virol 73 9679 9682

30. YuX

TsibaneT

McGrawPA

HouseFS

KeeferCJ

2008 Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455 532 536

31. SteelJ

LowenAC

PenaL

AngelM

SolorzanoA

2009 Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol 83 1742 1753

32. CatonAJ

BrownleeGG

YewdellJW

GerhardW

1982 The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31 417 427

33. ReedMuench

1938 A simple method of estimating fitty per cent endpoints. The American Journal of Hygiene 27 493 497

34. ArnoldK

BordoliL

KoppJ

SchwedeT

2006 The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22 195 201

35. DeLanoWL

2002 The PyMOL Molecular Graphics System Palo Alto, CA, USA DeLano Scientific http://www.pymol.org

36. HoyleL

1968 The influenza viruses.

GardS

HallauerC

MeyerKF

New York Springer 170 171

37. BelsheRB

2009 Implications of the emergence of a novel H1 influenza virus. N Engl J Med 360 2667 2668

38. BaslerCF

AguilarPV

2008 Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. Antiviral Res 79 166 178

39. MunsterVJ

de WitE

van den BrandJM

HerfstS

SchrauwenEJ

2009 Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325 481 483

40. MainesTR

JayaramanA

BelserJA

WadfordDA

PappasC

2009 Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325 484 487

41. EnserinkM

2009 Pandemic influenza. Ferrets shed light on new virus's severity and spread. Science 325 17

42. BrownleeGG

FodorE

2001 The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos Trans R Soc Lond B Biol Sci 356 1871 1876

43. TumpeyTM

Garcia-SastreA

TaubenbergerJK

PaleseP

SwayneDE

2004 Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A 101 3166 3171

44. SandbulteMR

JimenezGS

BoonAC

SmithLR

TreanorJJ

2007 Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4 e59 doi:10.1371/journal.pmed.0040059

45. PerroneLA

AhmadA

VeguillaV

LuX

SmithG

2009 Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 83 5726 5734

46. HensleySE

YewdellJW

2009 Que sera, sera: evolution of the swine H1N1 influenza A virus. Expert Rev Anti Infect Ther 7 763 768

47. BrightRA

CarterDM

DanilukS

ToapantaFR

AhmadA

2007 Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 25 3871 3878

48. RimmelzwaanGF

McElhaneyJE

2008 Correlates of protection: novel generations of influenza vaccines. Vaccine 26 Suppl 4 D41 44

49. GartenRJ

DavisCT

RussellCA

ShuB

LindstromS

2009 Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325 197 201

50. Van ReethK

GregoryV

HayA

PensaertM

2003 Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes. Vaccine 21 1375 1381

51. BikourMH

FrostEH

DeslandesS

TalbotB

ElazharyY

1995 Persistence of a 1930 swine influenza A (H1N1) virus in Quebec. J Gen Virol 76(Pt 10) 2539 2547

52. BikourMH

FrostEH

DeslandesS

TalbotB

WeberJM

1995 Recent H3N2 swine influenza virus with haemagglutinin and nucleoprotein genes similar to 1975 human strains. J Gen Virol 76(Pt 3) 697 703

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 1
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#